CDXS
Price
$1.78
Change
-$0.00 (-0.00%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
160.78M
42 days until earnings call
Intraday BUY SELL Signals
TNYA
Price
$0.74
Change
-$0.02 (-2.63%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
163.83M
68 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CDXS vs TNYA

Header iconCDXS vs TNYA Comparison
Open Charts CDXS vs TNYABanner chart's image
Codexis
Price$1.78
Change-$0.00 (-0.00%)
Volume$7.02K
Capitalization160.78M
Tenaya Therapeutics
Price$0.74
Change-$0.02 (-2.63%)
Volume$2.22K
Capitalization163.83M
CDXS vs TNYA Comparison Chart in %
CDXS
Daily Signal:
Gain/Loss:
TNYA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CDXS vs. TNYA commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a Hold and TNYA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (CDXS: $1.78 vs. TNYA: $0.76)
Brand notoriety: CDXS and TNYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 49% vs. TNYA: 49%
Market capitalization -- CDXS: $160.78M vs. TNYA: $163.83M
CDXS [@Biotechnology] is valued at $160.78M. TNYA’s [@Biotechnology] market capitalization is $163.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 1 FA rating(s) are green whileTNYA’s FA Score has 1 green FA rating(s).

  • CDXS’s FA Score: 1 green, 4 red.
  • TNYA’s FA Score: 1 green, 4 red.
According to our system of comparison, CDXS is a better buy in the long-term than TNYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 3 TA indicator(s) are bullish while TNYA’s TA Score has 4 bullish TA indicator(s).

  • CDXS’s TA Score: 3 bullish, 4 bearish.
  • TNYA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TNYA is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а +4.71% price change this week, while TNYA (@Biotechnology) price change was -5.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

CDXS is expected to report earnings on Feb 26, 2026.

TNYA is expected to report earnings on Mar 24, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNYA($164M) and CDXS($161M) have the same market capitalization . CDXS YTD gains are higher at: 9.202 vs. TNYA (6.451). CDXS has higher annual earnings (EBITDA): -55.32M vs. TNYA (-88.51M). CDXS (58.7M) and TNYA (56.3M) have equal amount of cash in the bank . TNYA has less debt than CDXS: TNYA (11.5M) vs CDXS (68.6M). CDXS has higher revenues than TNYA: CDXS (52.9M) vs TNYA (0).
CDXSTNYACDXS / TNYA
Capitalization161M164M98%
EBITDA-55.32M-88.51M63%
Gain YTD9.2026.451143%
P/E RatioN/AN/A-
Revenue52.9M0-
Total Cash58.7M56.3M104%
Total Debt68.6M11.5M597%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDXSTNYA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signal:
Gain/Loss:
TNYA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITEX3.090.39
+14.44%
ITEX Corp.
IOFNF0.380.02
+5.11%
Iofina Plc
KBGGY15.010.05
+0.30%
Kongsberg Gruppen ASA
SNBIF16.45N/A
N/A
Sanbio Co Ltd.
XYIGY21.39N/A
N/A
Xinyi Glass Holdings Ltd.

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+4.09%
DNLI - CDXS
51%
Loosely correlated
+0.88%
NTLA - CDXS
50%
Loosely correlated
+2.39%
BEAM - CDXS
50%
Loosely correlated
+2.49%
ABCL - CDXS
50%
Loosely correlated
+0.47%
ABSI - CDXS
49%
Loosely correlated
+1.21%
More

TNYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with VCYT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
-0.21%
VCYT - TNYA
40%
Loosely correlated
-1.39%
RCUS - TNYA
39%
Loosely correlated
+8.00%
CMMB - TNYA
37%
Loosely correlated
-1.12%
RXRX - TNYA
32%
Poorly correlated
+3.41%
CDXS - TNYA
32%
Poorly correlated
+4.09%
More